Bacterial resistance to antibiotics plays a major role in today’s medical world. A series of new hybrid antibiotics containing fluoroquinolone and aminoglycoside antibiotics were designed, synthesized and their antibacterial activities were determined. This combination yielded a new superior antibiotic: very potent on the one hand and resistant to bacterial resistance enzymes on the other.
Technion City, Senate Bldg., Haifa 32000, Israel
Tel. 972-4-829-4851; 972-8325-375